Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy PMV Pharmaceuticals stock | $34.4

Learn how to easily invest in PMV Pharmaceuticals stock.

PMV Pharmaceuticals, Inc
NASDAQ: PMVP - USD
BIOTECHNOLOGY
$34.01
-$0.84 (-2.41%)

PMV Pharmaceuticals, Inc is a biotechnology business based in the US. PMV Pharmaceuticals shares (PMVP) are listed on the NASDAQ and all prices are listed in US Dollars. PMV Pharmaceuticals employs 44 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in PMV Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PMVP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

PMV Pharmaceuticals stock price (NASDAQ: PMVP)

Use our graph to track the performance of PMVP stocks over time.

PMV Pharmaceuticals shares at a glance

Information last updated 2021-07-28.
Latest market close$34.40
52-week range$28.13 - $63.22
50-day moving average $33.62
200-day moving average $35.61
Wall St. target price$61.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy PMV Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PMV Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PMV Pharmaceuticals price performance over time

Historical closes compared with the close of $34.4 from 2021-05-28

1 week (2021-07-20) N/A
1 month (2021-07-01) 2.44%
3 months (2021-04-30) 1.99%
6 months (2021-01-27) N/A
1 year (2020-07-27) N/A
2 years (2019-07-27) N/A
3 years (2018-07-27) N/A
5 years (2016-07-27) N/A

PMV Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -9.32%
Return on equity TTM -17.36%
Profit margin 0%
Book value $7.76
Market capitalisation $1.6 billion

TTM: trailing 12 months

Shorting PMV Pharmaceuticals shares

There are currently 3.1 million PMV Pharmaceuticals shares held short by investors – that's known as PMV Pharmaceuticals's "short interest". This figure is 5.9% down from 3.3 million last month.

There are a few different ways that this level of interest in shorting PMV Pharmaceuticals shares can be evaluated.

PMV Pharmaceuticals's "short interest ratio" (SIR)

PMV Pharmaceuticals's "short interest ratio" (SIR) is the quantity of PMV Pharmaceuticals shares currently shorted divided by the average quantity of PMV Pharmaceuticals shares traded daily (recently around 449118.91495601). PMV Pharmaceuticals's SIR currently stands at 6.82. In other words for every 100,000 PMV Pharmaceuticals shares traded daily on the market, roughly 6820 shares are currently held short.

To gain some more context, you can compare PMV Pharmaceuticals's short interest ratio against those of similar companies.

However PMV Pharmaceuticals's short interest can also be evaluated against the total number of PMV Pharmaceuticals shares, or, against the total number of tradable PMV Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PMV Pharmaceuticals's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 PMV Pharmaceuticals shares in existence, roughly 70 shares are currently held short) or 0.1138% of the tradable shares (for every 100,000 tradable PMV Pharmaceuticals shares, roughly 114 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against PMV Pharmaceuticals.

Find out more about how you can short PMV Pharmaceuticals stock.

PMV Pharmaceuticals share dividends

We're not expecting PMV Pharmaceuticals to pay a dividend over the next 12 months.

PMV Pharmaceuticals overview

PMV Pharmaceuticals, Inc. , a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores p53 function. It is also developing p53 R273H mutation and other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013.

Stocks similar to PMV Pharmaceuticals

Frequently asked questions

What percentage of PMV Pharmaceuticals is owned by insiders or institutions?
Currently 11.948% of PMV Pharmaceuticals shares are held by insiders and 87.144% by institutions.
How many people work for PMV Pharmaceuticals?
Latest data suggests 44 work at PMV Pharmaceuticals.
When does the fiscal year end for PMV Pharmaceuticals?
PMV Pharmaceuticals's fiscal year ends in December.
Where is PMV Pharmaceuticals based?
PMV Pharmaceuticals's address is: 8 Clarke Drive, Cranbury, NJ, United States, 08512
What is PMV Pharmaceuticals's ISIN number?
PMV Pharmaceuticals's international securities identification number is: US69353Y1038

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site